Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John J Kavanagh

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Oncology (Williston Park, N.Y.)|July 11, 2002
Docetaxel in the treatment of ovarian cancerJohn J Kavanagh
Journal of Surgical Oncology|July 27, 2007
Intraperitoneal chemotherapy in the treatment of ovarian cancerJohn J Kavanagh
Current Oncology Reports|October 16, 2004
First-line chemotherapy trial in advanced endometrial carcinomaSiqing Fu, John J Kavanagh
The Lancet. Oncology|December 10, 2003
Anticancer therapy targeting the apoptotic pathwayWei Hu, John J Kavanagh
Cancer Investigation|December 3, 2004
Novel agents in epithelial ovarian cancerHui-Ti See, John J Kavanagh
Current Cancer Drug Targets|July 20, 2006
Targeted therapies in gynecologic cancersHye Sook Chon, Wei Hu, John J Kavanagh
The Lancet. Oncology|April 6, 2010
Targeted therapies for rare gynaecological cancersTarinee Manchana, Chupong Ittiwut, Apiwat Mutirangura, et al.
Current Oncology Reports|October 16, 2004
Proteomics in cancer screening and management in gynecologic cancerWei Hu, Weiguo Wu, Ryuji Kobayashi, et al.
Gynecologic and Obstetric Investigation|August 10, 2007
Hormone replacement therapy after treatment of endometrial cancerSiriwan Tangjitgamol, Sumonmal Manusirivithaya, Jitti Hanprasertpong, et al.
Expert Opinion on Therapeutic Targets|January 31, 2006
Targeting Aurora kinases in ovarian cancerSiqing Fu, Wei Hu, John J Kavanagh, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Oncology (Williston Park, N.Y.)|July 11, 2002
Docetaxel in the treatment of ovarian cancerJohn J Kavanagh
Journal of Surgical Oncology|July 27, 2007
Intraperitoneal chemotherapy in the treatment of ovarian cancerJohn J Kavanagh
Current Oncology Reports|October 16, 2004
First-line chemotherapy trial in advanced endometrial carcinomaSiqing Fu, John J Kavanagh
The Lancet. Oncology|December 10, 2003
Anticancer therapy targeting the apoptotic pathwayWei Hu, John J Kavanagh
Cancer Investigation|December 3, 2004
Novel agents in epithelial ovarian cancerHui-Ti See, John J Kavanagh
Current Cancer Drug Targets|July 20, 2006
Targeted therapies in gynecologic cancersHye Sook Chon, Wei Hu, John J Kavanagh
The Lancet. Oncology|April 6, 2010
Targeted therapies for rare gynaecological cancersTarinee Manchana, Chupong Ittiwut, Apiwat Mutirangura, et al.
Current Oncology Reports|October 16, 2004
Proteomics in cancer screening and management in gynecologic cancerWei Hu, Weiguo Wu, Ryuji Kobayashi, et al.
Gynecologic and Obstetric Investigation|August 10, 2007
Hormone replacement therapy after treatment of endometrial cancerSiriwan Tangjitgamol, Sumonmal Manusirivithaya, Jitti Hanprasertpong, et al.
Expert Opinion on Therapeutic Targets|January 31, 2006
Targeting Aurora kinases in ovarian cancerSiqing Fu, Wei Hu, John J Kavanagh, et al.
Pageof 5